Peramivir Trihydrate cas 1041434-82-5 for lab use
1041434-82-5
Pharmaceutical Grade
99%
qingdao
/
bag
2026-05-08
Medetomidine,Medetomidine hydrochloride,D-Lysergic Acid Methyl Ester,SR17018,Fluralaner,GS-441524
-
Product Description
-
Seller Information
-
DescriptionECHEMI Editorial ReferenceChEBI: A hydrate that is the trihydrate form of peramivir. Used for the treatment of acute uncomplicated influenza in patients 18 years and older who have been symptomatic for no more than two days.Basic Info
-
Product Name:
Peramivir Trihydrate
Other Name:Peramivir Trihydrate;BCX 1812 trihydrate;Rapiacta trihydrate;RWJ 270201 trihydrate;(1S,2S,3R,4R)-3-[(1S)-1-(Acetylamino)-2-ethylbutyl]-4-[(aminoiminomethyl)amino]-2-hydroxycyclopentanecarboxylic acid hydrate;PeraMivir trihydrate/3(R)-[1(S)-AcetaMido-2-ethylbutyl]-4(R)-guanidino-2(S)-hydroxycyclopentane-1(S)-carboxylic acid;PeraMivir Hydrate;eraMivir
CAS No.:1041434-82-5
Molecular Formula:C15H30N4O5
InChIKeys:DLIKIAYLVAIOME-KAJZLETJNA-N
Molecular Weight:346.43
EC Number:1308068-626-2
Color/Form:White to off-white
Categories:
Characteristics-
Critical Temperature & Pressure:
Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Medetomidine,Medetomidine hydrochloride,D-Lysergic Acid Methyl Ester,SR17018,Fluralaner,GS-441524
-
Location:
RONGSHENG BEIYUANDAJIE 9, LICHENG DISTRICT,JINAN, SHANDONG CHINA
-
Payment Terms:
TT against copy of documents,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
7
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
11-50
-
Year of Establishment:
2022
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product